INS and obesity disorder: Nevertheless, findings from non-pregnant studies indicate that succinate may act as a signalling metabolite influencing insulin secretion [26] and obesity-induced inflammation [27], and expression of the succinate receptor SUCNR1 has been demonstrated in human placenta [28].